DeepValuesResearch
CompaniesInsightsMarketGurusPrinciplesBuffett ArchivePersonal FinanceBusiness NotesLatestBullish stocksNeutral stocksBearish stocksSectorsMost covered For agents & developers

LENZHealthcare · Biotechnology

LENZ Therapeutics, Inc.

DeepValues Research covers LENZ Therapeutics (LENZ) with 1 research report since Mar 17, 2026. The latest Deep Value Intelligence report (Mar 17, 2026) ends with a Bearish stance (3.12/5). Sector: Healthcare · Biotechnology.

Latest stanceBearish3.12
Reports1since Mar 17, 2026
Latest reportEN

Research timeline

  1. Deep Value Intelligence

    LENZ Therapeutics, Inc. (LENZ) Deep Value Intelligence Report

    Bearish (3.12/5) on LENZ Therapeutics (LENZ), Mar 17, 2026. Price $12.5. LENZ Therapeutics is a pre-revenue, single-asset biotech company entirely…

    Bearish3.12EN36 min

Compare with other Healthcare companies

All Healthcare stocks
CompanyIndustryLatest stancePrice · valueDateReports
LENZLENZ Therapeutics Biotechnology Bearish3.12 $12.5 1
ALLOAllogene Therapeutics Biotechnology Bearish3.10 $1 1
MRNA Biotechnology Neutral3.01 $199 · $448 1
CRSPCRISPR Therapeutics Biotechnology Neutral2.30 $56 1
INSMInsmed Biotechnology Bearish2.52 $118 1
GMABGenmab A/S Biotechnology Bearish4.01 $29 1
MNKDMannKind Biotechnology Neutral2.63 $2 1
TPSTTempest Therapeutics Biotechnology Bearish2.65 $1.73 1
ADMAADMA Biologics Biotechnology Neutral3.37 $10 1

Charts from the latest report

Open report
Fundamentals Key MetricsFundamentals Key MetricsFundamentals Key MetricsYear Financial Metrics (Profitability)Year Financial Metrics (Health)Profitability MetricsRevenue BreakdownLatest Earnings SnapshotBalance Sheet & LiquidityCash Flow AnalysisMarket Metrics